BB-NCIPD
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
Related Content
Research & Development
Accelerating vaccine development with collaboration
BB-NCIPD (Bul Bio) and Stablepharma have recently entered into a partnership to produce the world’s first fridge-free tetanus diphtheria (Td) vaccine. And, having received very encouraging potency and accelerated thermostability data from animal challenge trials, Dr Kevin Robinson spoke to Mr Roumen Kofinov, MD, General Manager of Bul Bio, and Özgür Tuncer, CEO and Executive Director of Stablepharma, to find out more